首頁 > 市場調查報告書 > 醫療設備

醫院 IT

市場調查報告書

商品編碼

1616815

全球癌症登記軟體市場規模（按類型、部署模型、資料庫、功能、最終用戶、地區、範圍和預測）

Global Cancer Registry Software Market Size By Type, By Deployment Model, By Database, By Functionality, By End-User, By Geographic Scope And Forecast

出版日期: 2024年08月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

癌症登記軟體市場規模及預測

2023年癌症登記軟體市場規模為8,182萬美元，預計2024年至2031年複合年增長率為10.33%，2031年達到1.7964億美元。癌症登記軟體是一種專門的電腦應用程序，旨在收集、儲存和管理大量有關癌症患者的資料。這些應用程式在醫療保健領域非常重要，因為它們允許建立有組織的資料庫，其中包含有關個別癌症病例、治療方法、患者屬性和結果的資訊。癌症登記軟體是醫療保健專業人員研究和追蹤癌症發生率、盛行率和存活率趨勢的中央儲存庫。

其主要目的是透過提供有關癌症診斷和治療的準確、最新資訊來推進癌症研究、患者護理和公共衛生舉措。

這些軟體應用程式是癌症登記處的重要工具，使醫療機構能夠在國家和全球平台之間傳輸關鍵數據，以便更好地瞭解和對抗癌症。

癌症登記軟體市場動態

塑造癌症登記軟體市場的主要市場動態

主要市場推動因素

癌症發生率上升：

隨著癌症診斷領域的不斷發展，對組織和評估隨附資料的有效工具的需求不斷增長。癌症登記軟體在這方面非常重要，是一個關鍵的市場推動因素，因為它提供了一個準確報告、監測和調查的平台，最終實現了更強有力的癌症控制。

加強優質照護和臨床研究：

對提高服務品質和支援臨床研究的重視也推動了癌症登記軟體的採用。這些技術有助於提高數據準確性、治療計劃和資源分配，進而改善患者的治療效果。

數據驅動的決策與公共衛生監測：

這些系統的數據為公共衛生政策和舉措提供信息，從而實現更有針對性的預防和早期檢測計劃。這有利於地方和國家層級的風險評估、資源分配和癌症趨勢追蹤。因此，數據驅動的決策和公共衛生監測正在推動癌症登記軟體的使用。

主要挑戰

與現有醫療保健 IT 系統整合：

由於不同的數據標準和供應商鎖定，將癌症登記軟體與現有的醫療保健 IT 系統（尤其是電子健康記錄 (EHR)）整合極為困難。與互通性相關的複雜性對於獲得對癌症模式和治療結果的完整和一致的瞭解至關重要，並對癌症註冊軟體市場的成長提出了挑戰。

高初始投資：

開發和維護癌症登記軟體所需的高昂初始成本對於小型醫療機構來說尤其具有挑戰性。平衡實施癌症登記軟體的成本與長期效益仍然是醫療保健組織面臨的主要挑戰。

新的技術挑戰：

將人工智慧 (AI) 和機器學習 (ML) 整合到現有工作流程中，同時保護病患隱私和資料完整性是一項需要智慧解決方案的挑戰。因此，將人工智慧和機器學習整合到癌症登記軟體中既會帶來機遇，也會帶來障礙。

主要趨勢

強調患者的治療結果：

癌症登記軟體正在興起，透過為醫生提供即時數據和見解來做出更有針對性的治療決策，以支持個人化醫療的目標。透過患者入口網站和行動應用程式等功能，患者互動變得越來越重要。

基於雲端的部署將成為推動因素：

醫療保健公司越來越多地轉向基於雲端的解決方案，因為它們提供了更大的靈活性、可擴展性和可訪問性。由於成本降低和 IT 基礎設施要求降低，預計這一趨勢將持續下去。

與人工智慧和機器學習整合：

人工智慧驅動的系統正在開發中，以實現腫瘤檢測、分期和風險評估的自動化。這提高了數據準確性和效率，從而改善患者護理和研究結果。

癌症登記軟體市場的區域分析

以下是癌症登記軟體市場更詳細的區域分析：

北美：

根據 Verified Market Research 的數據，由於癌症發生率高、醫療基礎設施發達、政府支持和先進的技術實施方法，北美將在預測期內主導癌症登記軟體市場。

北美擁有發達的醫療基礎設施和強大的政府資助，使其成為實施癌症登記軟體等尖端技術的理想環境。

在這個不斷發展的行業中，北美正在優先考慮電子健康記錄 (EHR) 整合、採用人工智慧驅動的分析以及全面的數據洞察等關鍵領域，以推動個人化護理。EHR 整合可確保統一且全面的病患記錄系統，簡化資訊流並提高醫療保健服務的整體效率。

此外，IT 實施的改進使得將癌症登記軟體整合到現有醫療保健系統中變得更加容易，從而鞏固了該地區作為 IT 解決方案熱衷用戶的地位。

歐洲：

歐洲癌症登記軟體產業的成長是由多種因素推動的，包括癌症發病率上升、強大的醫療保健系統、政府鼓勵癌症登記的要求以及對資料保護和互通性的承諾。

歐洲擁有優秀的醫療保健系統，該系統依賴實證方法並專注於公共衛生。癌症登記軟體整合符合這些概念，並為醫療保健產業的實證決策、資源分配和策略規劃奠定了基礎。

該地區對現代、可互通的癌症登記解決方案的渴望不僅是因為強調確保健康資訊系統的順利通訊和集成，而且還因為嚴格的資料隱私要求。

此外，該地區癌症發生率的上升也增加了對先進系統有效收集、組織和分析癌症相關數據的需求。

亞太地區：

由於癌症發病率上升、醫療保健支出大幅增加、政府大力加強醫療保健基礎設施以及數位醫療技術的加速採用，亞太地區處於全球數據的前沿，預計將成為該地區成長最快的市場。

該地區數位醫療技術的使用正在增加。在醫療保健中使用數位技術（例如癌症登記軟體）有助於高效的數據管理，改善醫療保健專業人員之間的協作，並促進基於證據的決策。

此外，生活方式的改變、預期壽命的延長和環境變數都會導致癌症發生率上升，因此需要專注於亞太地區的癌症管理和研究。

Cancer Registry Software Market size was valued at USD 81.82 Million in 2023 and is projected to reach USD 179.64 Million by 2031, growing at a CAGR of 10.33% from 2024 to 2031. Cancer registry software is a type of specialized computer application that is designed to collect, store, and manage extensive data about cancer patients. These applications are important in healthcare because they allow for the establishment of organized databases containing information about individual cancer cases, treatment modalities, patient demographics, and results. Cancer registry software is a central repository for medical professionals to study and track trends in cancer incidence, prevalence, and survival rates.

The primary goal is to promote cancer research, patient care, and public health initiatives by providing accurate and current information about cancer diagnosis and treatments.

These software applications are critical tools for cancer registries, allowing healthcare organizations to transfer vital data across national and worldwide platform to better understand and combat cancer.

Cancer Registry Software Market Dynamics

The key market dynamics that are shaping the Cancer Registry Software Market include:

Key Market Drivers

Rising Cancer Burden:

With an increasing global prevalence of cancer diagnoses, there is a greater demand for effective tools to organize and evaluate the accompanying data. Cancer registry software is critical in this context because it provides a platform for accurate reporting, monitoring, and research, ultimately leading to enhanced cancer control measures, thereby serving as a key market driver.

Enhanced Quality Care and Clinical Research:

The emphasis on improving service quality and supporting clinical research has also aided in the adoption of cancer registry software. These technologies help to enhance data accuracy, treatment planning, and resource allocation, leading to better patient outcomes.

Data-Driven Decision-Making and Public Health Surveillance:

These systems' data feed public health policies and initiatives allow for more targeted preventative and early detection programs. This, in turn, facilitates risk assessment, resource allocation, and cancer trend tracking at the regional and national levels. As a result, data-driven decision-making and public health surveillance are driving the use of cancer registry software.

Key Challenges:

Integration with Existing Healthcare IT Systems:

The integration of cancer registry software with existing healthcare IT systems, particularly electronic health records (EHRs), is extremely difficult due to different data standards and vendor lock-in. The complexity associated with interoperability is critical to getting full and coherent insights into cancer patterns and treatment results, thereby challenging the growth of the Cancer Registry Software Market.

High Upfront Investment:

The significant initial cost necessary to develop and maintain cancer registry software presents a difficulty, especially for smaller healthcare organizations. Balancing the expenses of deploying cancer registry software compared to the possible long-term benefits remains an important consideration for healthcare institutions.

Emerging Technological Challenges:

Integrating artificial intelligence (AI) and machine learning (ML)into existing workflows while maintaining patient privacy and data integrity presents a challenge that necessitates smart solutions. Thus, integrating AI and ML into cancer registry software creates both potential and obstacles.

Key Trends:

Focus on Patient Outcomes:

Cancer registry software is emerging to support personalized medicine ambitions by providing doctors with real-time data and insights to make more tailored treatment decisions. Patient interaction is becoming increasingly important, with features such as patient portals and mobile apps as a key trend in the market.

Cloud-Based Deployment Gaining Traction:

Healthcare organizations are increasingly turning to cloud-based solutions because they offer greater flexibility, scalability, and accessibility. This trend is projected to continue, driven by cost savings and lower IT infrastructure requirements.

Integration with AI and Machine Learning:

AI-powered systems are being developed to automate tumor detection, staging, and risk assessment. This can increase data accuracy and efficiency, resulting in better patient care and research findings.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Cancer Registry Software Market Regional Analysis

Here is a more detailed regional analysis of the Cancer Registry Software Market:

North America:

According to Verified Market Research, North America is estimated to dominate in Cancer Registry Software Market during the forecast period owing to the region's high cancer burden, well-established healthcare infrastructure, government support, and a forward-thinking approach to technology adoption.

The well-developed healthcare infrastructure in North America, combined with significant government financing initiatives is creating an atmosphere suitable for the adoption of modern technology such as cancer registry software.

In this growing industry, North America prioritizes critical areas such as integrating with Electronic Health Records (EHRs), employing AI-powered analytics, and advancing personalized treatment through comprehensive data insights. Integration with EHRs ensures a unified and comprehensive patient record system, which streamlines information flow and improves overall healthcare delivery efficiency.

Furthermore, the region's dedication to leverage IT solutions strengthens its position, since improved IT adoption allows for the easy integration of cancer registry software into existing healthcare systems.

Europe:

The rise in the cancer registry software industry in Europe has been attributed to several factors, including rising cancer incidence, strong healthcare systems, governmental requirements encouraging cancer registries, and a dedication to data protection and interoperability.

Europe boasts excellent healthcare systems that rely on evidence-based methods and focus on public health. The integration of cancer registry software is consistent with these concepts, laying the groundwork for evidence-based decision-making, resource allocation, and strategic planning in the healthcare industry.

The region's desire for modern, interoperable cancer registry solutions is influenced by stringent data privacy requirements as well as an emphasis on ensuring smooth communication and integration of health information systems.

Furthermore, the rising prevalence of cancer in the region has increased the need for sophisticated systems to efficiently collect, organize, and analyze cancer-related data.

Asia Pacific:

Asia-Pacific is estimated to be the fastest-growing market in the global data fabric environment, driven by the increasing prevalence of cancer, a significant uptick in healthcare spending, proactive government initiatives to bolster healthcare infrastructure, and the accelerating adoption of digital health technologies.

This region is seeing increased usage of digital health technologies. The use of digital technologies in healthcare, such as cancer registry software, aids efficient data administration, improves cooperation among healthcare professionals, and promotes evidence-based decision-making.

Furthermore, lifestyle changes, higher life expectancy, and environmental variables all contribute to the rising cancer rate, necessitating a greater emphasis on cancer management and research in Asia Pacific.

Global Cancer Registry Software Market: Segmentation Analysis

The Global Cancer Registry Software Market is segmented on the basis of Type, Deployment Mode, Database, Functionality, End-User, And Geography.

Cancer Registry Software Market, By Type

Integrated Software
Standalone Software

Based on Type, the market is segmented into Integrated Software and Standalone Software. The Standalone Software type segment is estimated to dominate the market over the forecast period. This growth is attributable to its extensive capability, easy-to-use features, and inherent adaptability. Standalone software solutions function independently of other systems, allowing healthcare organizations to customize and seamlessly integrate with existing infrastructures. These systems offer end users a dedicated platform for cancer registry maintenance, allowing for fast data gathering, analysis, and reporting.

Cancer Registry Software Market, By Deployment Mode

On-Premise
Cloud-Based

Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. On-premise segment is estimated to dominate the Cancer Registry Software Market during the forecast period. Several factors contribute to the on-premise deployment segment's dominance in the Cancer Registry Software Market, including addressing the specific demands and preferences of healthcare institutions. The on-premise implementation offers a great level of control and flexibility, allowing healthcare companies to adjust the software to their specific needs while seamlessly integrating it with existing infrastructure. This level of personalization is especially important in the healthcare industry, where data security and adherence to regulatory norms are critical.

Cancer Registry Software Market, By Database

Commercial Databases
Public Databases

Based on the Database, the market is segmented into Commercial and Public Databases. The commercial database segment is estimated to hold a major share of the market during the forecast period. Commercial databases provide comprehensive and user-friendly solutions that address the complex needs of healthcare practitioners, researchers, and administrators. The Commercial Databases segment's dominance is further supported by their smooth integration capabilities, interoperability, and scalability, which allow them to meet the different needs of healthcare institutions and research organizations.

Cancer Registry Software Market, By Functionality

Cancer Reporting
Patient Care Management
Product Outcome Evaluation
Medical Research and Clinical Studies

Based on Functionality, the market is segmented into Cancer Reporting, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. The cancer reporting segment is estimated to hold the majority share in the forecast period in the Cancer Registry Software Market. Its vital function in aggregating and managing detailed data on cancer cases are enabling the segment retain its top position. Accurate and timely reporting of cancer information is critical for healthcare institutions, regulatory agencies, and researchers to understand disease patterns, assess treatment outcomes, and develop effective public health measures. Cancer reporting software accelerates data collection, organization, and analysis, assuring regulatory compliance and enhancing the overall quality of cancer-related information.

Cancer Registry Software Market, By End-User

Government Organizations & Third-party Administrators
Hospitals & Medical Practices
Pharmaceutical, Biotechnology, & Medical Device Companies
Private Payers
Research Centers

Based on End-User, the market is segmented into Government Organizations & Third-party Administrators, Hospitals & Medical Practices, Pharmaceutical, Biotechnology & Medical Device Companies, Private Payers, and Research Centers. The Government Organizations & Third-party Administrators segment is estimated to show the highest growth in the forecasted period. Government entities, such as public health agencies and regulatory authorities, play an important role in the collection, analysis, and dissemination of cancer-related data for public health research and policy. The necessity for comprehensive cancer registries is consistent with public health objectives such as disease trend monitoring, prevention planning, and resource allocation optimization.

Key Players

The "Global Cancer Registry Software Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
C/NET Solutions, IBM Corporation, Siemens Healthineers, McKesson Corporation, Elekta, Epic Systems, Cerner Corporation, NextGen Healthcare, SCC Soft Computer, Elekta Oncology, Varian Medical Systems, GE Healthcare, Philips Healthcare, Meditech, Agfa HealthCare. Carestream Health, eClinicalWorks, and iSOFT Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Oncology, allowing it to match patients to suitable clinical trials based on their medical data. This collaboration with cancer registries could greatly improve patient access to potentially life-saving clinical trials.
In November 2023, C/NET Solutions, a prominent cancer registry software provider, announced a partnership with pharmaceutical giant Roche to develop real-world data solutions for cancer research and treatment. The collaboration aims to leverage C/NET's OncologyOne platform and Roche's expertise in oncology data analytics.
In October 2023, McKesson, a renowned healthcare IT business, acquired eHealth Technologies, a cloud-based cancer registry software vendor (eCancerRegistry). This transaction boosts McKesson's oncology offering and broadens its presence in the cancer registry market.
In September 2023, Elekta and IBM Watson Health collaborated to create a data interchange platform for cancer registries. This technology will enable the secure sharing of patient data between cancer centers, hence boosting research and tailored care initiatives.

1 INTRODUCTION OF GLOBAL CANCER REGISTRY SOFTWARE MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANCER REGISTRY SOFTWARE MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY TYPE

5.1 Overview
5.2 Integrated Software
5.3 Standalone Software

6 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY DATABASE

6.1 Overview
6.2 Commercial Databases
6.3 Public Databases

7 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

7.1 Overview
7.2 Cancer Reporting
7.3 Patient Care Management
7.4 Product Outcome Evaluation
7.5 Medical Research and Clinical Studies

8 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY END USER

8.1 Overview
8.2 Government Organizations & Third-Party Administrators
8.3 Hospitals & Medical Practices
8.4 Private Payers
8.5 Pharmaceutical, Biotechnology, and Medical Device Companies
8.6 Research Centre

9 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East & Africa

10 GLOBAL CANCER REGISTRY SOFTWARE MARKETCOMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 C/NET Solutions
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 IBM Corporation
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Siemens Healthineers
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 McKesson Corporation
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Elekta
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Epic Systems
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Cerner Corporation
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments